TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

NCT03615144 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Participant accrual low and the study was closed

Conditions

Non-Malignant Hematologic Disorders

Interventions

DRUG: Melphalan
DRUG: Thiotepa
DRUG: Clofarabine
DRUG: Fludarabine
DRUG: Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®)
PROCEDURE: CliniMACS reagents

Sponsor

Memorial Sloan Kettering Cancer Center